In a legal development that has sent shockwaves through the multi-billion-dollar pet food industry, the United States Court of Appeals has breathed new life into a lawsuit that accuses one of the world’s largest pet food manufacturers of orchestrating a massive disinformation campaign. The case, KetoNatural Pet Foods v. Hill’s Pet Nutrition, alleges that Hill’s—along with a network of affiliated veterinary researchers—concocted a fraudulent link between grain-free dog foods and a deadly heart condition to reclaim lost market share from smaller, independent competitors.
The litigation centers on Canine Dilated Cardiomyopathy (DCM), a disease that weakens the heart muscle. For years, the pet-owning public has been warned that "boutique, exotic, and grain-free" (BEG) diets were a primary driver of a sudden spike in DCM cases. However, the lawsuit suggests that this "science" was less about canine health and more about corporate warfare.
Main Facts: A "Faux-Scientific" Scheme Revealed
The lawsuit, originally filed in February 2024 by KetoNatural Pet Foods—a small, independent manufacturer based in Utah—presents a staggering 124-page complaint. It alleges that Hill’s Pet Nutrition, a subsidiary of the global conglomerate Colgate-Palmolive, engaged in a coordinated effort to deceive pet owners, veterinarians, and federal regulators.
According to the complaint, Hill’s observed a significant erosion of its market dominance as consumers shifted toward grain-free and high-protein diets produced by independent firms. To counter this, KetoNatural alleges that Hill’s utilized a network of "knowing and unknowing" partners, including veterinary nutritionists with deep financial ties to the company, to manufacture a health crisis.
The core of the allegation is that Hill’s and its associates "cherry-picked" DCM cases to create a statistical illusion. By reporting only cases involving grain-free diets to the Food and Drug Administration (FDA) while ignoring similar cases in dogs eating grain-inclusive diets, the defendants allegedly induced the FDA to launch a public investigation that devastated the grain-free market.
KetoNatural’s legal team describes the campaign as "egregious, wide-ranging, and damaging," claiming it was designed to "falsely convince American dog owners that a massive, unrelated, and hugely diverse group of dog food products—essentially any product made by any of the hundreds of independent firms… increase the risk and severity of DCM."
Chronology: From FDA Alerts to the Appeals Court
The timeline of the DCM controversy is critical to understanding the weight of the current legal battle.
- July 2018: The FDA issues its first public alert, stating it is investigating a potential link between certain diets (largely grain-free) and DCM. This sparked a media firestorm and led to a sharp decline in sales for independent pet food brands.
- 2018–2020: A series of papers and presentations by veterinary nutritionists, many of whom served as consultants for Hill’s, Purina, or Mars, reinforced the narrative that "BEG" diets were dangerous.
- February 2024: KetoNatural Pet Foods files its initial lawsuit against Hill’s Pet Nutrition in the U.S. District Court, alleging violations of the Lanham Act (false advertising) and trade libel.
- Early 2024: A lower court dismisses the lawsuit, citing that many of the statements made by Hill’s were protected as "scientific opinion" or did not constitute "commercial speech."
- November 2024: The U.S. Court of Appeals for the Tenth Circuit reverses the dismissal. The appellate judges determined that KetoNatural had "plausibly alleged" that Hill’s statements were indeed commercial speech and were "literally false."
- July 2025: A pivotal study funded by Hill’s is published, which—ironically—debunks the very link the company was accused of promoting.
Supporting Data: The "Smoking Gun" Study and the Four-Year Delay
One of the most damning pieces of evidence highlighted in the wake of the lawsuit is a study published in July 2025 titled "Different carbohydrate sources in dog foods supported overall health and cardiac function: an 18-mo prospective study in healthy adult dogs."
The study was conducted by Hill’s Pet Nutrition scientists and funded entirely by the corporation. It followed a double-blind, randomized trial of dogs fed various diets, including grain-free options. The conclusion was unequivocal: "Both grain-free and grain-inclusive diets providing complete and balanced nutrition supported normal cardiac function in healthy adult dogs."
However, the controversy lies in the dates of the research. The feeding trial was completed on August 25, 2021. Despite having data that exonerated grain-free diets as early as late 2021, Hill’s did not publish the results until July 2025—four years after the trial ended and years after the grain-free market had already suffered billions in losses.
Critics and the plaintiffs argue that this delay was intentional. By withholding the data, Hill’s allegedly allowed the "fear-based" narrative to persist in veterinary clinics and pet stores, ensuring that their grain-inclusive "Science Diet" products remained the "safe" choice for concerned pet owners.
Furthermore, the lawsuit points to the statistical anomalies in the FDA reporting. While the FDA received over 1,100 reports of DCM between 2014 and 2019, the complaint alleges that the reporting process was heavily influenced by "social media echo chambers" and veterinary professionals who were coached to focus on grain-free brands, thereby creating a self-fulfilling prophecy of data.
Official Responses and Legal Arguments
In its defense, Hill’s Pet Nutrition has consistently argued that its communications regarding DCM were a matter of public interest and scientific inquiry, not deceptive marketing. The company maintained that the statements on its website—which claimed "trends" like grain-free or raw diets could "pose health risks"—were true based on the information available at the time.
Hill’s legal team argued that for a statement to be actionable under the Lanham Act, it must be "commercial speech" intended to influence a consumer’s purchase. They contended that sharing scientific concerns about canine heart health did not meet this threshold.
However, the Appeals Court disagreed. The court noted that Hill’s had a clear financial incentive to disparage grain-free competitors. By linking these products to a fatal disease, Hill’s was effectively promoting its own grain-heavy products. The court stated, "KetoNatural has plausibly alleged that some statements and links on Hill’s webpages are commercial speech… KetoNatural has also plausibly alleged that these statements are literally false."
This ruling is significant because it strips away the "scientific opinion" shield that large corporations often use to deflect false advertising claims. It opens the door for a discovery phase where KetoNatural’s lawyers can examine internal Hill’s documents, emails, and communications with the FDA and veterinary partners.
Implications: Trust, Monopolies, and the Future of Pet Nutrition
The implications of this lawsuit extend far beyond a single legal battle. It touches upon the very foundation of trust between pet owners and the veterinary community.
1. The Erosion of Veterinary Trust
For years, veterinarians have been the primary advocates for the "Big Three" manufacturers (Hill’s, Mars, and Purina). If the allegations are proven true, it would suggest that the veterinary community was used as a conduit for corporate propaganda. This could lead to a significant rift between pet owners and their vets, as consumers may begin to question whether nutritional advice is based on science or sponsorship.
2. Regulatory Capture
The lawsuit raises uncomfortable questions about the FDA’s role. The complaint suggests that a federal agency was essentially "weaponized" by a private corporation to target competitors. If the FDA’s investigation was indeed sparked by manipulated data, it points to a major failure in regulatory oversight and a susceptibility to "regulatory capture," where an industry leader exerts undue influence over the agency meant to monitor it.
3. Market Monopolization
The DCM scare successfully shifted the market. Many small, independent pet food companies went out of business or were forced to change their formulations at great expense. If these companies were victims of a "faux-scientific" scheme, the pet food industry may see a wave of secondary lawsuits seeking damages for lost revenue and brand defamation.
4. The "Corn is King" Narrative
For decades, the pet food industry has been divided between those who promote grain-heavy diets (utilizing corn, wheat, and soy) and those who promote "ancestral" or grain-free diets. The DCM controversy effectively framed corn as a "magical superfood" that prevented heart disease—a claim that lacks robust biological evidence. The resolution of this lawsuit may finally debunk the idea that grain-inclusive diets are inherently superior for cardiac health.
As the case moves forward, it promises to provide an unprecedented look into the inner workings of the pet food industry. For pet owners like Susan Thixton, a prominent consumer advocate, the lawsuit is a "brave" attempt to hold massive corporations accountable. "It will give pet owners an inside look into what some manufacturers will do to make money—the lengths they go through, the schemes they develop to manipulate the public," Thixton noted.
The pet food industry now waits to see if the "mystery novel" described in the 124-page complaint ends in a settlement or a landmark trial that could redefine how pet food is marketed and regulated in the United States.
